Market revenue in 2021 | USD 1,086.2 million |
Market revenue in 2028 | USD 1,064.0 million |
Growth rate | -0.3% (CAGR from 2021 to 2028) |
Largest segment | Pcr-based amplification |
Fastest growing segment | Nucleic Acid Sequence Based Amplification (NASBA) |
Historical data covered | 2018 - 2020 |
Base year for estimation | 2021 |
Forecast period covered | 2022 - 2028 |
Quantitative units | Revenue in USD million |
Market segmentation | PCR-based Amplification, Loop Mediated Isothermal Amplification (LAMP), Nucleic Acid Sequence Based Amplification (NASBA), Strand Displacement Amplification (SDA), Multiple displacement amplification (MDA), Rolling Circle Amplification (RCA), Ramification amplification method (RAM) |
Key market players worldwide | Qiagen NV, Illumina Inc, Bio-Rad Laboratories Inc, Silicon Laboratories Inc, Merck KGaA, Promega, Takara Bio Inc, Danaher Corp, New England Biolabs, 4Basebio, LGC Group, Vazyme Biotech, MyBiosource |
Key Regions: U.S. , UK , Japan , Brazil , South Africa
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to gene amplification technologies market will help companies and investors design strategic landscapes.
Pcr-based amplification was the largest segment with a revenue share of 90.62% in 2021. Horizon Databook has segmented the Middle East & Africa gene amplification technologies market based on pcr-based amplification, loop mediated isothermal amplification (lamp), nucleic acid sequence based amplification (nasba), strand displacement amplification (sda), multiple displacement amplification (mda), rolling circle amplification (rca), ramification amplification method (ram) covering the revenue growth of each sub-segment from 2018 to 2028.
Middle East & African countries are estimated to have the lowest share in the market. This low share can be attributed to the lack of funds for healthcare research and unavailability of skilled personnel & advanced technology. Furthermore, presence of ethical, social, and legal barriers pertaining to cell based therapies, especially stem-cell based, significantly restricts growth of the region.
However, adoption of an intermediate national policy by countries, such as Iran and Turkey, is expected to support noticeable growth. These policies encourage stem cell research as well as allow use of existing cell lines for research purpose.
However, the region is witnessing growing research and development and application of gene amplification technologies with the increasing engagement of researchers and local companies in the field of genomics.
Horizon Databook provides a detailed overview of continent-level data and insights on the Middle East & Africa gene amplification technologies market , including forecasts for subscribers. This continent databook contains high-level insights into Middle East & Africa gene amplification technologies market from 2018 to 2028, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account